Adherence to Statins and LDL-Cholesterol Goal Attainment

被引:0
|
作者
Chi, Margaret D. [1 ]
Vansomphone, Southida S. [2 ]
Liu, In-Lu Amy [1 ]
Cheetham, T. Craig [2 ]
Green, Kelley R. [3 ]
Scott, Ronald D. [4 ]
Reynolds, Kristi [1 ]
机构
[1] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA
[2] Kaiser Permanente, Pharm Analyt Serv, Downey, CA USA
[3] Kaiser Permanente So Calif, Permanente Med Grp, Pasadena, CA 91101 USA
[4] Kaiser Permanente So Calif, West Los Angeles Med Ctr, Los Angeles, CA USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2014年 / 20卷 / 04期
关键词
LONG-TERM PERSISTENCE; HEART-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CORONARY; THERAPY; STROKE; ASSOCIATION; UPDATE;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To examine the relationship between low-density lipoprotein cholesterol (LDL-C) goal attainment and adherence to statin medications in patients with coronary artery disease (CAD). Study Design: Cross-sectional study of CAD patients 18 years of age or older in an integrated healthcare system. Methods: Patients dispensed 2 or more statin prescriptions between May 2009 and May 2010, were identified. Medication possession ratio (MPR) was calculated to estimate adherence. The LDL-C value closest to May 27, 2010, was used to determine goal. Adherence and LDL-C goal were defined as 80% or greater MPR and less than 100 mg/dL or less than 70 mg/dL, respectively. Electronic medical records were used to identify patient demographics and clinical information. Logistic regression was used to estimate the effect of these factors on goal attainment. Results: A total of 67,100 CAD patients were identified. Overall, 85.8% had LDL-C less than 100 mg/dL, 32.4% had LDL less than 70 mg/dL, and 79.8% were adherent to their statin medication. Over 65% of patients not at LDL-C goal less than 100 mg/dL were adherent. Among patients with LDL-C less than 100 mg/dL, 17.9% were not adherent. Increasing medication adherence was associated with improved LDL-C levels. Adherence to statins, male sex, Asian and Hispanic race/ethnicity, a higher number of concurrent prescriptions, higher Charlson Comorbidity Index, and hypertension were associated with LDL-C goal attainment. Conclusions: Incorporating LDL-C levels and medication adherence at the point of care allows providers to focus interventions to address either adherence challenges or the need for medication titration in an effort to improve LDL-C goal attainment and ultimately reduce morbidity and mortality.
引用
收藏
页码:E105 / E112
页数:8
相关论文
共 50 条
  • [1] Time to LDL-cholesterol goal attainment in Spain
    Olivares, Q
    Mabe, I
    Nocea, G
    Alemao, E
    Caloto, T
    Fosbrook, L
    Ahumada, C
    Yin, D
    VALUE IN HEALTH, 2004, 7 (06) : 685 - 685
  • [2] Adherence to statin therapy and attainment of guidelines - LDL-Cholesterol therapeutic objectives
    Kitio, Brice
    Laforest, Laurent
    Massol, Jacques
    Van Ganse, Eric
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S161 - S161
  • [3] COMPARISON OF PATIENTS' ADHERENCE AND LDL-CHOLESTEROL GOAL ATTAINMENT IN 2010 AND 2013 IN THE HUNGARIAN MULTI GAP 2012 STUDY
    Mark, L.
    Reiber, I.
    Paragh, G.
    Karadi, I.
    Pados, G.
    Kiss, R. G.
    Kiss, Z.
    ATHEROSCLEROSIS, 2014, 235 (02) : E278 - E279
  • [4] INTENSITY OF LIPID-LOWERING THERAPY, ADHERENCE AND LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS WITH CORONARY HEART DISEASE
    Mazhar, F.
    Hjemdahl, P.
    Clase, C. M.
    Johnel, K.
    Jernberg, T.
    Carrero, J. J.
    ATHEROSCLEROSIS, 2022, 355 : E301 - E301
  • [5] Statins and LDL-cholesterol lowering: an overview
    Stroes, E
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 : S9 - S16
  • [6] Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy
    Laforest, Laurent
    Moulin, Philippe
    Souchet, Thierry
    Ritleng, Cecile
    Desamericq, Gaelle
    Le Jeunne, Philippe
    Schwalm, Marie-Sophie
    Kieffer, Alexia
    Van Ganse, Eric
    ATHEROSCLEROSIS, 2008, 199 (02) : 368 - 377
  • [7] LDL-cholesterol goal attainment among patients treated with lipid lowering drugs in Spain
    García-Ruiz, FJ
    Marín, A
    Pérez-Jimenez, F
    Pintó, X
    Nocea, G
    Casado, MA
    Erbey, J
    Alemao, EA
    Yi, DD
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 119 - 119
  • [8] Adherence to lipid lowering drugs is associated with ldl-cholesterol goal achievement.
    Pladevall, M.
    Williams, K. L.
    Lafata, J. Elston
    Tunceli, K.
    Wang, M.
    Campbell, I.
    Divine, G.
    Yang, J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S11 - S11
  • [9] Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia
    Parris, ES
    Lawrence, DB
    Mohn, LA
    Long, LB
    DIABETES CARE, 2005, 28 (03) : 595 - 599
  • [10] Therapeutic options to reduce LDL-cholesterol beyond statins
    Weingaertner, Oliver
    Marx, Nikolaus
    Klose, Gerald
    Laufs, Ulrich
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (15) : 1001 - 1011